A prospective, interventional, randomized, double-blind, placebo-controlled study to evaluate the safety and effectiveness of IND02 capsules (Cinamuneâ?¢) in SARS-CoV2 positive patients with mild to moderate COVID-19, managed as per the Government of India COVID-19 management guidelines, at COVID-19 management centres offering integrated Ayurvedic care.
Pilot experimental study for safety and efficacy of IND02 (standardized hydroalcoholic extract of Cinnamonum zeylanicum bark extract) in reducing symptoms of Seasonal Allergic Rhinitis.
开始日期2018-01-20
申办/合作机构-
100 项与 HIV envelope protein gp120 x APOBEC3G 相关的临床结果
登录后查看更多信息
100 项与 HIV envelope protein gp120 x APOBEC3G 相关的转化医学
登录后查看更多信息
0 项与 HIV envelope protein gp120 x APOBEC3G 相关的专利(医药)